0001127602-13-010792.txt : 20130314
0001127602-13-010792.hdr.sgml : 20130314
20130314161506
ACCESSION NUMBER: 0001127602-13-010792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130312
FILED AS OF DATE: 20130314
DATE AS OF CHANGE: 20130314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPA JOSEPH C
CENTRAL INDEX KEY: 0001242215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19725
FILM NUMBER: 13690664
MAIL ADDRESS:
STREET 1: C/O WATSON PHARMACEUTICALS INC
STREET 2: 311 BONNIE CIRCLE
CITY: CORONA
STATE: CA
ZIP: 92880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERRIGO CO
CENTRAL INDEX KEY: 0000820096
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 382799573
STATE OF INCORPORATION: MI
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
BUSINESS PHONE: 2696738451
MAIL ADDRESS:
STREET 1: 515 EASTERN AVENUE
CITY: ALLEGAN
STATE: MI
ZIP: 49010
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-03-12
0000820096
PERRIGO CO
PRGO
0001242215
PAPA JOSEPH C
C/O PERRIGO COMPANY
515 EASTERN AVENUE
ALLEGAN
MI
49010
1
1
1
President and CEO
Chairman
Common Stock
2013-03-12
4
S
0
10000
116.0945
D
105645
D
Common Stock
2013-03-12
4
M
0
5000
30.06
A
110645
D
Common Stock
2013-03-12
4
S
0
3000
116.3295
D
107645
D
Common Stock
2013-03-12
4
S
0
2000
117.5043
D
105645
D
Employee Stock Option Right to Buy
30.06
2013-03-12
4
M
0
5000
0
D
2010-08-25
2019-08-25
Common Stock
5000
7186
D
This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 8, 2012. This 10b5-1 sales plan will expire on the close of business November 8, 2013.
The price in column 4 is a weighted average. The prices actually received ranged from $115.63 to $116.49. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $116.06 to $116.75. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
The price in column 4 is a weighted average. The prices actually received ranged from $117.30 to $117.65. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
/s/ Penny Bursma, Attorney-in-fact for Joseph C. Papa
2013-03-14